Medicine & Life Sciences
Atypical Hemolytic Uremic Syndrome
100%
Complement Factor I
69%
Thrombotic Microangiopathies
65%
Complement Factor H
51%
Macular Degeneration
47%
Complement Activation
45%
eculizumab
35%
Kidney
34%
Complement Receptors
31%
Mutation
27%
ravulizumab
23%
Transplants
22%
Membranoproliferative Glomerulonephritis
21%
Kidney Transplantation
19%
Alternative Complement Pathway
18%
Complement System Proteins
17%
Pre-Eclampsia
15%
Membranous Glomerulonephritis
12%
Coronavirus
12%
Hemolysis
12%
Autoimmune Diseases
11%
Polymerization
10%
Geographic Atrophy
10%
Cytomegalovirus
10%
Platelet Count
9%
Postpartum Period
9%
Podocytes
9%
Chronic Kidney Failure
8%
Antiphospholipid Syndrome
8%
Complement C3-C5 Convertases
7%
Complement Inactivating Agents
7%
resmethrin
7%
Proteins
7%
Epithelial Cells
7%
L-Lactate Dehydrogenase
7%
Kidney Diseases
7%
Calcium
6%
Protein Deficiency
6%
Therapeutics
6%
Antigen-Antibody Complex
6%
Quality of Life
6%
Systemic Lupus Erythematosus
6%
Clinical Pathology
6%
Electron Microscopy
6%
Endothelial Cells
6%
Autoantibodies
6%
Serum
6%
Creatinine
5%
Fibrinogen
5%
Enzymes
5%